latest news releases from the newsroom
Southcoast Financial Corporation
Southcoast Declines Troubled Assets Relief Program Funds and Announces 2008 Year End Earnings
MT. PLEASANT, S.C., Feb. 4, 2009 (GLOBE NEWSWIRE) -- Southcoast Financial Corporation (Nasdaq:SOCB) announced today that the Company has declined to participate in the U.S. Department of the Treasury's Capital Purchase Program, even though it had applied for and received preliminary approval. The Capital Purchase Program is not a "bailout" but is an offer by the Treasury to make an investment in the Company on terms that are disadvantageous to existing shareholders. The Company has determined that participation in the program would be dilutive to existing shareholders, subject the Company to a constantly increasing administrative burden and expose the Company to unknown future restrictions on its business. The Company believes that it has sufficient capital to meet its foreseeable needs. It also believes that other capital raising alternatives will be available should a need for additional capital arise.
Penwest Pharmaceuticals Co.
Penwest to Present At 11th Annual BIO CEO & Investor Conference
DANBURY, Conn., Feb. 4, 2009 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that Jennifer Good, President and Chief Executive Officer of Penwest, will be presenting at the 11th Annual BIO CEO & Investor Conference taking place at the Waldorf-Astoria in New York City on February 9-10, 2009. Ms. Good will be presenting on Tuesday, February 10 at 2:45 pm EST.
MiddleBrook Pharmaceuticals, Inc.
MiddleBrook Pharmaceuticals Retains Almac Pharma Services(r) to Produce Physician Samples of MOXATAG(tm)
WESTLAKE, Texas, Feb. 4, 2009 (GLOBE NEWSWIRE) -- MiddleBrook Pharmaceuticals, Inc. (Nasdaq:MBRK), a pharmaceutical company committed to developing anti-infective products that fulfill unmet medical needs, today announced that it has retained Almac Pharma Services(r) to provide packaging services for physician samples of MOXATAG (amoxicillin extended-release) Tablets, 775 mg. Almac Pharma Services(r) will work closely with MiddleBrook's chosen commercial manufacturer, STADA Production Ireland(r).
Ultrapetrol (Bahamas) Limited
Ultrapetrol to Present At BB&T Capital Markets 24th Annual Transportation Services Conference
NASSAU, Bahamas, Feb. 4, 2009 (GLOBE NEWSWIRE) -- Ultrapetrol (Bahamas) Limited (Nasdaq:ULTR), an industrial transportation company serving marine transportation needs in four markets (River Business, Offshore Supply Business, Ocean Business and Passenger Business), announced today that it is scheduled to present at the BB&T Capital Markets 24th Annual Transportation Services Conference in Coral Gables, FL on Wednesday, February 11, 2009. Felipe Menendez Ross, President and Chief Executive Officer, will speak to the investment community at 10:15 a.m. ET.
OPNET Technologies, Inc.
OPNET Announces Financial Results for Third Quarter of Fiscal 2009
BETHESDA, Md., Feb. 4, 2009 (GLOBE NEWSWIRE) -- OPNET Technologies, Inc. (Nasdaq:OPNT), a leading provider of solutions for managing networks and applications, today announced that revenue for the third fiscal quarter, ended December 31, 2008, was $31.5 million, compared to $26.0 million for the same quarter in the prior fiscal year. Diluted earnings per share for the third quarter of fiscal 2009 were $0.10, compared to diluted earnings per share of negative $0.06 for the same quarter in the prior fiscal year.